跳至主要内容
临床试验/DRKS00027842
DRKS00027842招募中未知

Telemedicine monitoring of patients with severe aortic stenosis and planned transcatheter aortic valve implantation (TAVI) under normal conditions and when treatment capacity is limited due to crisis. - ResKriVer-TAVI

Charité Campus Charité Mitte0 个研究点目标入组 200 人开始时间: 2022年5月16日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • Patient with decision for TAVI in case of severe aortic stenosis in the heart team, age of majority, written consent of the patient.

排除标准

  • Inability or unwillingness to take daily vital signs (e.g., dementia, blindness, deafness, wheelchair use, insufficient German language skills, limited informal self-determination), Participation in therapy studies (observational studies and registries are possible).

研究者

发起方
Charité Campus Charité Mitte

相似试验